logo
Questions? +1 (202) 335-3939 Login
Set Up FREE Account Submit Release
Trusted News Since 1995
A service for pharmaceutical industry professionals · Sunday, November 17, 2024 · 761,314,161 Articles · 3+ Million Readers
Home  •••  Newswires by Industry  •  Countries  •  U.S. States  •  World Media Directory
Pharmaceutical Industry News  •••  Topics  •  Countries  •  U.S. States

Acne Medications News Monitoring

  • Published on Apr 4, 2024

    Onglyza Lawsuit Lawyers

    Onglyza May Increase Death Rate   AstraZeneca Diabetes Drug Increase Risk Of Death. A review published by the U.S. Food and Drug Administration (FDA) on April 10, 2015 indicates that Astra Zeneca’s key diabetes drugs-Onglyza (saxagliptin)-may be tied to “a …

    Source: Parker Waichman LLP - Neutral
  • Published on Apr 4, 2024

    Ocaliva Chronic Liver Disease Lawsuit Lawyers

    PARKER WAICHMAN LLP – OCALIVA CHRONIC LIVER DISEASE LAWSUIT LAWYERS   Parker Waichman LLP is currently investigating potential Ocaliva chronic liver disease lawsuits for individuals with primary biliary cholangitis (PBC) who have suffered serious liver …

    Source: Parker Waichman LLP - Neutral
  • Published on Apr 4, 2024

    Empagliflozin/Metformin Amputation Lawsuits

    Renowned Plaintiffs’ Law Firm Parker Waichman LLP is Actively Pursuing Damages for Diabetics Who Lost Limbs and Suffered Other Injuries from Taking Synjardy.   National plaintiffs’ law firm Parker Waichman LLP is currently investigating claims on behalf of …

    Source: Parker Waichman LLP - Neutral
  • Published on Apr 4, 2024

    Protonix Injury Lawyers

    Protonix is part of a class of medications known as proton pump inhibitors or PPIs. Proton pump inhibitors help relieve gastrointestinal issues such as stomach ulcers and acid reflux by preventing the stomach from creating too much acid. However, these …

    Source: Parker Waichman LLP - Neutral
  • Published on Apr 4, 2024

    Actemra RA Medicine Side Effects May be Deadly

    Actemra RA Medicine Serious Side Effects. Actemra is used in the treatment of rheumatoid arthritis (RA) and has been linked to serious side effects including cardiovascular and pulmonary disease, pancreatitis, and gastrointestinal perforation. The U.S. …

    Source: Parker Waichman LLP - Neutral
  • Published on Apr 4, 2024

    Inadequate Warnings of Serious Side Effects of Proton Pump Inhibitors

    Proton Pump Inhibitors Side Effects. Millions of Americans suffer from heartburn, acid reflux and similar digestive conditions and many of them take a proton pump inhibitor (PPI) medication to provide relief from the condition. PPIs ease heartburn and acid …

    Source: Parker Waichman LLP - Neutral
  • Published on Apr 4, 2024

    Witness Gives Damning Xarelto Testimony

    Xarelto is a powerful anti-coagulant drug that is suspected to cause severe, life-threatening internal bleeding. The drug is believed to have caused over 18,000 patients to suffer adverse symptoms, and out of those 18,000, 370 have died from taking the …

    Source: Parker Waichman LLP - Neutral
  • Published on Apr 4, 2024

    Limbrel Liver Damage Lawsuit Lawyers

    FDA Alerts Consumers to Potentially Life-Threatening Side Effects from Taking Limbrel Parker Waichman LLP Cautions Limbrel Users to Watch for Potentially Lethal Side Effects   Parker Waichman LLP learned the Limbrel, manufactured by Primus Pharmaceuticals, …

    Source: Parker Waichman LLP - Neutral
  • Published on Apr 4, 2024

    Document Suggests Bayer and JJ Misled Top Medical Journal

    Xarelto And The Alleged Deception Plaintiffs’ attorneys in Xarelto litigation point to a document that allegedly shows Bayer and Johnson & Johnson deceived the editors of a top medical journal. According to the New York Times, the issue stems from a …

    Source: Parker Waichman LLP - Neutral
  • Published on Apr 4, 2024

    Proton Pump Inhibitors May Lead To Birth Defect Lawsuits

    The risks that an infant will be born with a birth defect Proton Pump Inhibitors Injury Lawsuits. Where you treated with a proton pump inhibitor during pregnancy, only to give birth to a child with birth defects? Studies have indicated that proton pump …

    Source: Parker Waichman LLP - Neutral
  • Published on Apr 4, 2024

    SSRI Antidepressant Violence Lawsuit Lawyers

    Receive A Monetary Award for Wrongful Deaths and Injuries Linked to Use of Antidepressant Medication People take medication with the hopes of improving their lives, not destroying them. Regrettably, people have been harmed by others who never displayed a …

    Source: Parker Waichman LLP - Neutral
  • Published on Apr 4, 2024

    Dolutegravir Lawsuit Lawyers

    HIV Medication Dolutegravir Linked to Neural Tube Defects in Infants   The United States Food and Drug Administration (FDA) released a warning to pregnant women about the risks of infants being born with neural tube defects if they are exposed to …

    Source: Parker Waichman LLP - Neutral
  • Published on Apr 4, 2024

    Xarelto Linked to Serious Internal Bleeding and Blood Clots

    This is known as a pulmonary embolism and may be a life-threatening condition. Xarelto Bleeding Lacks Antidote Xarelto (rivaroxaban), one of a newer class of blood thinners, has been linked to serious internal bleeding and blood clots Blood thinners are …

    Source: Parker Waichman LLP - Neutral
  • Published on Apr 4, 2024

    Empagliflozin/Linagliptin Amputation Lawsuit

    Glyxambi Amputation Attorneys Parker Waichman LLP is reviewing claims that sodium-glucose cotransporter inhibitors-2 (SGLT2) like Glyxambi have resulted in people living with Type-2 diabetes losing a lower extremity such as a toe, partial foot, foot, or …

    Source: Parker Waichman LLP - Neutral
  • Published on Apr 4, 2024

    Empagliflozin / Metformin Amputation Lawsuit Lawyer

    How to Ensure That You Receive Full Compensation for Your Sodium-Glucose Cotransporter 2 Inhibitor Amputation Lawsuit Synjardy is a Sodium-Glucose Cotransporter 2 inhibitor (SGLT2) drug manufactured by Boehringer Ingelheim and Lilly. Synjardy is the brand …

    Source: Parker Waichman LLP - Neutral
  • Published on Apr 4, 2024

    Prevacid Lawsuit Lawyers

    Prevacid and Prevacid 24 Hour Attorneys Prevacid and Prevacid 24 Hours are part of a group of drugs known as Proton Pump Inhibitors or PPI’s which are used for a multitude of gastrointestinal issues, like severe heartburn. Prevacid was one of the first …

    Source: Parker Waichman LLP - Neutral
  • Published on Apr 4, 2024

    Invokana Amputation Lawsuit Lawyers

    The United States Food and Drug Administration (“FDA”) cleared the sale and marketing of the type 2 diabetes drug Invokana (canagliflozin) in March of 2013. In Europe, the European Medicines Agency (also known as the “EMA”), approved Invokana for sale and …

    Source: Parker Waichman LLP - Neutral
  • Published on Apr 4, 2024

    Taxotere Lawsuit Lawyers

    Get Full and Just Compensation for Your Permanent Hair Loss Due to Taxotere Hair loss, called alopecia, is expected when taking a chemotherapy drug. However, a cancer victim’s hair typically regrows within three or four months after stopping the …

    Source: Parker Waichman LLP - Neutral
  • Published on Apr 4, 2024

    Bayer, J&J Faces New Xarelto Wrongful Death Lawsuit

      Xarelto Wrongful Death Lawsuit. Litigation Continues to Mount over Xarelto Wrongful Death Lawsuit. A new wrongful death lawsuit has been filed over the anticoagulant Xarelto against Janssen Pharmaceuticals, parent company Johnson & Johnson and Bayer …

    Source: Parker Waichman LLP - Neutral

02 days 00:19:52

Send 2 Free
Press Releases
Use them anytime within 12 months

Featured Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.
Load more pharmaceuticals news or search news using your own keywords. There are 761,314,161 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country >
Pharmaceutical Industry News by U.S. State >
Pharmaceutical Industry News Topics >
Online News Publications >
World News Report >

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter >
Create RSS Feed >
NewsPlugin for WordPress >

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire >
Events >

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 10/20/2024

World Media Directory >

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.

Healthcare & Pharmaceuticals Events

See All

No event was found.

Become a Member - Join Today!
Join thousands of professionals. Stay current. Stay competitive.
  • Track news from thousands of sources
  • Submit news sources for inclusion in our news tracking algorithm
  • Build your own customized email newsletters
  • Use of our RSS Feeds
  • Includes a complimentary EIN Presswire account plus 1-free release
  • Uncluttered & advertising free news pages

Pharmaceutical Industry Today by EIN Newsdesk & EIN Presswire (a press release distribution service)

Follow us on Facebook & Twitter and connect with us on LinkedIn

Newsmatics Inc., 1025 Connecticut Avenue NW, Suite 1000, Washington, DC 20036 · Contact · About

© 1995-2024 Newsmatics Inc., a publisher of EIN News · All Rights Reserved · Privacy Policy · User Agreement